The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...

Delcath Systems, Inc. announced the publication of a retrospective study reporting outcomes from patients with liver-dominant ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...

Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.